FreeStyle Libre 3 App, part of Continuous Glucose Monitoring System, when used on the Android 13 Operating System
Published January 24, 2024 · Recall initiated: February 9, 2023
Summary
FDA records medical device Class II recall Z-0734-2024, published January 24, 2024 and initiated February 9, 2023. Recalling firm: Abbott Diabetes Care, Inc.; Status: Completed; Reported quantity: 45,173; Lot: UDI-DI: 00357599816001, Software v.3.4.0 and below. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
If using affected glucose monitoring app on Android 13 Operating System, extended periods of signal loss may be experienced, due to app not connected, which could impact ability to receive glucose reading/alarms, which could lead to undetected low or high glucose, which could result in delayed treatment: not taking insulin (for high glucose), or not taking glucose (for low glucose) when required.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Abbott Diabetes Care, Inc.
- Distributor
- US Nationwide distribution in the states of NY, CA, NJ, UT, PA, MS, OH, TX, MN, FL, LA, NE, MI, VA, NC, MA, IN, SC, IA.
- Lot
- UDI-DI: 00357599816001, Software v.3.4.0 and below
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAFreeStyle Libre 3 Sensors, REF: 72081-01, component of the FreeStyle Libre 3 Continuous Glucose MonitoringSeptember 4, 2024
- FDAVACUETTE TUBE 4 ml FX Sodium Fluoride/Potassium Oxalate, Item #454297, 13x75 grey cap-black ring, non-ridged.January 24, 2024
- FDATECNIS Toric II OptiBlue IOL Models ZCWJanuary 24, 2024
- FDAPrecision Xtra Blood Glucose & Ketone Monitoring System, UDI: 00093815715023, 00093815988144April 1, 2020
- FDAFreeStyle Flash Blood Glucose Monitors System. Meter made in China; Distributed by TheraSense, Alameda, CA TheMarch 26, 2014
- FDAFreeStyle Blood Glucose Monitors System. For in vitro diagnostic use only. Store at room temperature below 86March 26, 2014
Questions about this recall
Was FreeStyle Libre 3 App, part of Continuous Glucose Monitoring System, when used on the Android 13 Operating System recalled?
Yes. FDA published recall Z-0734-2024 on January 24, 2024. Reported hazard: If using affected glucose monitoring app on Android 13 Operating System, extended periods of signal loss may be experienced, due to app not connected, which could impact ability to receive glucose reading/alarms, which could lead to undetected low or high glucose, which could result in delayed treatment: not taking insulin (for high glucose), or not taking glucose (for low glucose) when required.
What should I do if I have this product?
Voluntary: Firm initiated · Letter